Figure 11

Consequences of P-AgNPs treatment on the cancer and normal cell viability. (A) presents the bar graph that indicates the dose–response of P-AgNPs on a normal cell line; MCF 10A and two human cancer cell lines; MDA MB 231 and HCT116 viability. (B) displays the effect of Log concentration of biogenic NPs against the normalized cell viability of one normal cell line MCF 10A and two human cancer cell lines; MDA MB 231 and HCT116.